ASTRO congratulates Dr. Stephen Hahn for securing Senate committee approval to lead U.S. Food and Drug Administration
American Society for Radiation Oncology (ASTRO)The American Society for Radiation Oncology (ASTRO) expressed its support after the U.S. Senate Committee on Health, Education, Labor and Pensions voted today to approve the nomination of radiation oncologist Stephen Hahn, MD, FASTRO, as the next Commissioner of the Food and Drug Administration (FDA).